000 | 01837 a2200553 4500 | ||
---|---|---|---|
005 | 20250513230842.0 | ||
264 | 0 | _c20010412 | |
008 | 200104s 0 0 eng d | ||
022 | _a0017-5749 | ||
024 | 7 |
_a10.1136/gut.48.3.339 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aShah, A A | |
245 | 0 | 0 |
_aSelective inhibition of COX-2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxen. _h[electronic resource] |
260 |
_bGut _cMar 2001 |
||
300 |
_a339-46 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aBiomarkers |
650 | 0 | 4 | _aCross-Over Studies |
650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xadverse effects |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGastric Mucosa _xdrug effects |
650 | 0 | 4 |
_aGastrointestinal Diseases _xchemically induced |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntestinal Mucosa _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNaproxen _xadverse effects |
650 | 0 | 4 |
_aPermeability _xdrug effects |
650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
650 | 0 | 4 |
_aProstaglandins E _xmetabolism |
650 | 0 | 4 |
_aSulfonamides _xadverse effects |
650 | 0 | 4 |
_aThromboxane B2 _xblood |
700 | 1 | _aThjodleifsson, B | |
700 | 1 | _aMurray, F E | |
700 | 1 | _aKay, E | |
700 | 1 | _aBarry, M | |
700 | 1 | _aSigthorsson, G | |
700 | 1 | _aGudjonsson, H | |
700 | 1 | _aOddsson, E | |
700 | 1 | _aPrice, A B | |
700 | 1 | _aFitzgerald, D J | |
700 | 1 | _aBjarnason, I | |
773 | 0 |
_tGut _gvol. 48 _gno. 3 _gp. 339-46 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/gut.48.3.339 _zAvailable from publisher's website |
999 |
_c11110721 _d11110721 |